Fundraising Fox
RetinalGenix Technologies
OTC: RTGNApollo Beach, US · Founded 2017 · Delaware corporation
Find your way into RetinalGenix Technologies
Sign up to see every warm intro you have to RetinalGenix Technologies
- Paths you didn't know you had: your email and LinkedIn already hold routes to the RetinalGenix Technologies team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
RetinalGenix develops a high-resolution retinal imaging device for mass screening that does not require pupil dilation, aimed at early detection of ocular, neuro-degenerative, cardiovascular, vascular, metabolic, and diabetic conditions. The technology targets screening for both eye diseases and systemic diseases.
Founders & leadership
Board
VM
Vinay MehindruBoard director
HG
Herbert GouldBoard director
Reported raises · per SEC filings
Form D private placements$698.1K disclosed across 2 rounds · 2021–2024
▶$653.1KraisedFeb 2025 · 30 investors · BiotechnologyRule 506(b)
▶$653.1KraisedFeb 2025 · 30 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jerry KatzmanExecutive Officer, Director
- Vinay MehindruDirector
- Herbert GouldDirector
- Offering amount
- $5M
- Amount sold
- $653.1K
- First sale
- Jan 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$45KraisedJul 2021 · 3 investors · Other Health CareRule 506(b)
▶$45KraisedJul 2021 · 3 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- HERBERT GOULDDirector
- JERRY KATZMANExecutive Officer, Director
- Offering amount
- $7M
- Amount sold
- $45K
- First sale
- Jun 2021
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does RetinalGenix Technologies do?
- RetinalGenix develops a high-resolution retinal imaging device for mass screening that does not require pupil dilation, aimed at early detection of ocular, neuro-degenerative, cardiovascular, vascular, metabolic, and diabetic conditions. The technology targets screening for both eye diseases and systemic diseases.
- How much funding has RetinalGenix Technologies raised?
- RetinalGenix Technologies has disclosed $698.1K raised across 2 rounds.
- Where is RetinalGenix Technologies headquartered?
- RetinalGenix Technologies is headquartered in Apollo Beach, US.